- Marketwired•2 days agoCannabis Science Negotiates an Additional 200 Acres in California and 100 Acres in Nevada for Indoor and Outdoor Grow and Production Operations, Keys for Large-Scale Nationwide Growth Strategy
Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicines, today announced they are in the process of negotiating for another couple of major new drug development ...
- Marketwired•4 days agoCBIS Breaking News: Polling by UC Berkeley Recently Shows Nearly 2:1 Voting Support Passing Proposition 64 in California; CNET Reports: Virgin's Sir Richard Branson to Cannabis Advocates: Fight to Legalize it
Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicines, announces latest polls in "California vote yes to Proposition 64," showing a substantial margin ...
- Marketwired•8 days agoExcitement for Proposition 64 Mounts in California and Propels Cannabis Science to Release More New Products While Discharging Stigmas by Legalizing Use of Cannabis in the State of California
Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicines, feels empowered to be based in California, representing one of the largest cannabis markets in the USA, ...
Cannabis Science, Inc. (CBIS)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||0.06 - 0.08|
|52wk Range||0.01 - 0.08|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-8.38|
|Avg Vol (3m)||19,645,546|
|Dividend & Yield||N/A (N/A)|